Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PFKFB4 inhibitors(6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC11H6N6O6 |
InChIKeySABYAGFCTHBRAA-UHFFFAOYSA-N |
CAS Registry2664831-55-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | China | 01 Dec 2025 |





